---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-026762"
form_type: "8-K/A"
ticker: "QCLS"
cik: "0001321834"
company_name: "Q/C TECHNOLOGIES, INC."
filed_at: "2025-09-05T23:59:59+00:00"
generated_at: "2026-05-17T07:53:27.075009+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# TNF Pharmaceuticals acquires LPU Holdings LLC for Series I Preferred Stock plus contingent milestones

## Summary
- TNF to acquire 100% of LPU Holdings LLC; closing consideration is Series I Convertible Preferred Stock convertible into 747,362 common shares.
- Contingent milestone payments include 6.25%/5% of equity offering proceeds up to $50M and a one-time share payment representing 10% of fully diluted shares upon reaching $50M aggregate proceeds.
- Additional $1.75M payment (cash/equity) if TNF market cap reaches $100M for 10 consecutive trading days after 90 days post-closing.
- Concurrent equity offering of at least $7.5M at $5.00/sh (Series H preferred) is a condition to closing.
- Acquisition includes a License Agreement with LightSolver Ltd. for technology rights.

## SEC filing metadata
- accession: 0001641172-25-026762
- form_type: 8-K/A
- ticker: QCLS
- cik: 0001321834
- company_name: Q/C TECHNOLOGIES, INC.
- filed_at: 2025-09-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1321834/000164117225026762/0001641172-25-026762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1321834/000164117225026762/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-026762
- JSON: https://secwatch.observer/filing/0001641172-25-026762.json
- Plain text: https://secwatch.observer/filing/0001641172-25-026762.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.